# Abbott Laboratories: Form 8-K, filed Feb 20, 2026

- Company: [Abbott Laboratories](/companies/abt.md) (CIK 1800)
- Form: 8-K
- Filed: 2026-02-20
- Accepted by EDGAR: Feb 20, 2026, 16:17 ET
- Period: 2026-02-20
- Accession: 0001104659-26-018167
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1800/000110465926018167/tm266807d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1800/000110465926018167/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1800/000110465926018167/tm266807d1_8k.htm

Filed Feb 20, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-018167. Last ingested by Listed: Nov 6, 2026, 18:17 ET. No prices; not investment advice.